4.1 Contributo in Atti di convegno

4.1 Contributo in Atti di convegno: [15358] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 8.961 a 8.980 di 15.358

Intermittent bile acid therapy of cholesterol gallstones: a 5-year prospective multicentre trial.

1992-01-01 M. L., Petroni; R. P., Jazrawi; M., Zuin; E., Boga; Lanzini, Alberto; D., Facchinetti; M., Fracchia; G., Galatola; D., Sighinolfi; P., Pazzi; K. W. H., Heaton; R., Ferraris; V., Alvisi; M., Podda; T. C., Northfield

Hydrolyzed protein based materials for biodegradable spray mulching coatings

2010-01-01 G., Vox; Sartore, Luciana; A., Sassi; M., Barbaglio; E., Schettini

Gallstone pattern on computerised tomografy (CT) is of value in predicting response to bile acid therapy.

1992-01-01 M. L., Petroni; R. P., Jazrawi; A., Grundy; Lanzini, Alberto; M. G., Pigozzi; A., Biasio; K., Heaton; J., Virjee; T. C., Northfield

Nuovi materiali polimerici biodegradabili da risorse rinnovabili

2010-01-01 Sartore, Luciana; Barbaglio, Marzia; A., Sassi; G., Vox; E., Schettini

Prospective study on value of CT scanning in predicting response to bile acid therapy.

1992-01-01 M. L., Petroni; Jazrawi, R. P.; A., Grundy; Lanzini, Alberto; M. G., Pigozzi; A., Biasio; K., Heaton; J., Virjee; T. C., Northfield

Biodegradable plastics based on Collagen Hydrolysate and poly(ethylene-co-vinyl acetate)

2007-01-01 Sartore, Luciana; A., Sassi

Sensore piezoelettrico modificato con polimeri per il rilevamento dei metalli pesanti nell’acqua

2008-01-01 Sartore, Luciana; Barbaglio, Marzia; Bontempi, Elza; P., Colombi; Depero, Laura Eleonora

Intermittent bile acid therapy for recurrent cholesterol gallstones: a 5 year prospective multicentre trial.

1992-01-01 Podda, M; Northfield, Tc; Lanzini, Alberto

Increased retention of a bile acid analogue in the enterohepatic circulation (EHC) in chronic cholestasis: effect of ursodeoxycholic acid (UDCA). -

1995-01-01 DE TAVONATTI, M.; Panarotto, M. B.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto

Efficacy of interferon (IFN) alone vs IFN + tauroursodeoxycholic acid (t-UDCA) in the treatment of chronic active hepatitis C (CHH-C). --

1995-01-01 Pigozzi, M. G.; R., Sorbara; A., Reggiani; D., Quattrocchi; Lorini, G. P.; C., Valsecchi; G., Viviani; M., DE TAVONATTI; A., Rotondi; L., Bettini; P., Tebaldi; Lanzini, Alberto

75 Selena Homocholic acid-Taurine (74SeHCAT) retention in the enterohepatic circulation (EHC) in chronic cholestasis: comparison with normal controls and effect of ursodeoxycholic acid (UDCA)

1995-01-01 DE TAVONATTI, M.; Panarotto, Mb; Maira, G.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto

Interferon (IFN) treatment for chronic active hepatitis C (CAH-C): efficacy of IFN alone vs combination treatment with tauro-ursodeoxycholic acid (t-UDCA)

1995-01-01 Mg, Pigozzi; R., Sorbara; A., Reggiani; D., Quattrocchi; Gp, Lorini; C., Lazzari; C., Valsecchi; G., Viviani; M., DE TAVONATTI; A., Rotondi; L., Bettini; P., Tebaldi; Lanzini, Alberto

Incidence of autoantibodies in selected patients with chronic hepatitis C (CHC) during interferon (IFN) treatment, and prevalence in unselected patients.

1995-01-01 Sorbara, R.; Pigozzi, Mg; Tebaldi, P.; Franceschini, F.; Lanzini, Alberto

Does inhibition of cholesterol synthesis during ursodeoxycholic acid( UDCA) therapy enrich the pool with UDCA more than UDCA treatment alone?

1995-01-01 Mb, Panarotto; R., Sorbara; F., Lanzarotto; S., Sosta; Lanzini, Alberto

Does combination of ursodeoxycholic acid (UDCA) and HMG-CoA-Reductase inhibitors enrich the pool with UDCA more than UDCA treatment alone?

1995-01-01 B., Panarotto; R., Sorbara; F., Lanzarotto; S., Sosta; Lanzini, Alberto

Prevalence of autoantibodies in patients with chronic hepatitis C ( CHC), and incidence during interferon (IFN) treatment.

1995-01-01 Sorbara, R.; Pigozzi, Mg; Tebaldi, P.; Franceschini, F.; Lanzini, Alberto

Efficacy of interferon (IFN) alone vs IFN+ tauro-ursodeoxycholic acid (T-UDCA) for treatment of chronic hepatitis C ( CHA-C): result at 12 months.

1996-01-01 R., Sorbara; Mg, Pigozzi; A., Reggiani; D., Quattrocchi; Gp, Lorini; C., Lazzari; G., Viviani; M., DE TAVONATTI; A., Rotondi; L., Bettini; Lanzini, Alberto

Chronic tauro-hyodeoxycholic acid administartion has little effect on bile acid composition and on biliary lipid secretion in man.

1999-01-01 G., Montani; F., Lanzarotto; S., Sosta; Lanzini, Alberto

Interferon (IFN) sparing effect of adjuvant tauro-ursodeoxycholic acid 8T-UDCA) for treatment of chronic hepatitis C. Results on liver histology.

1999-01-01 Mg, Pigozzi; L., DI STEFANO; F., Lanzarotto; O., Baisini; A., Reggiani; MG DE, Tavonatti; L., Bettini; Gp, Lorini; A., Cominotti; M., Favret; Lanzini, Alberto

Osteopenia in adult patients with coeliac disease: biochemical characteristics and relationship with bone mineral density.

1998-01-01 F., Lanzarotto; Lanzini, Alberto

Titolo	Data di pubblicazione	Autore(i)
Intermittent bile acid therapy of cholesterol gallstones: a 5-year prospective multicentre trial.	1-gen-1992	M. L., Petroni; R. P., Jazrawi; M., Zuin; E., Boga; Lanzini, Alberto; D., Facchinetti; M., Fracchia; G., Galatola; D., Sighinolfi; P., Pazzi; K. W. H., Heaton; R., Ferraris; V., Alvisi; M., Podda; T. C., Northfield
Hydrolyzed protein based materials for biodegradable spray mulching coatings	1-gen-2010	G., Vox; Sartore, Luciana; A., Sassi; M., Barbaglio; E., Schettini
Gallstone pattern on computerised tomografy (CT) is of value in predicting response to bile acid therapy.	1-gen-1992	M. L., Petroni; R. P., Jazrawi; A., Grundy; Lanzini, Alberto; M. G., Pigozzi; A., Biasio; K., Heaton; J., Virjee; T. C., Northfield
Nuovi materiali polimerici biodegradabili da risorse rinnovabili	1-gen-2010	Sartore, Luciana; Barbaglio, Marzia; A., Sassi; G., Vox; E., Schettini
Prospective study on value of CT scanning in predicting response to bile acid therapy.	1-gen-1992	M. L., Petroni; Jazrawi, R. P.; A., Grundy; Lanzini, Alberto; M. G., Pigozzi; A., Biasio; K., Heaton; J., Virjee; T. C., Northfield
Biodegradable plastics based on Collagen Hydrolysate and poly(ethylene-co-vinyl acetate)	1-gen-2007	Sartore, Luciana; A., Sassi
Sensore piezoelettrico modificato con polimeri per il rilevamento dei metalli pesanti nell’acqua	1-gen-2008	Sartore, Luciana; Barbaglio, Marzia; Bontempi, Elza; P., Colombi; Depero, Laura Eleonora
Intermittent bile acid therapy for recurrent cholesterol gallstones: a 5 year prospective multicentre trial.	1-gen-1992	Podda, M; Northfield, Tc; Lanzini, Alberto
Increased retention of a bile acid analogue in the enterohepatic circulation (EHC) in chronic cholestasis: effect of ursodeoxycholic acid (UDCA). -	1-gen-1995	DE TAVONATTI, M.; Panarotto, M. B.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto
Efficacy of interferon (IFN) alone vs IFN + tauroursodeoxycholic acid (t-UDCA) in the treatment of chronic active hepatitis C (CHH-C). --	1-gen-1995	Pigozzi, M. G.; R., Sorbara; A., Reggiani; D., Quattrocchi; Lorini, G. P.; C., Valsecchi; G., Viviani; M., DE TAVONATTI; A., Rotondi; L., Bettini; P., Tebaldi; Lanzini, Alberto
75 Selena Homocholic acid-Taurine (74SeHCAT) retention in the enterohepatic circulation (EHC) in chronic cholestasis: comparison with normal controls and effect of ursodeoxycholic acid (UDCA)	1-gen-1995	DE TAVONATTI, M.; Panarotto, Mb; Maira, G.; Franceschini, F.; Lanzarotto, F.; Lanzini, Alberto
Interferon (IFN) treatment for chronic active hepatitis C (CAH-C): efficacy of IFN alone vs combination treatment with tauro-ursodeoxycholic acid (t-UDCA)	1-gen-1995	Mg, Pigozzi; R., Sorbara; A., Reggiani; D., Quattrocchi; Gp, Lorini; C., Lazzari; C., Valsecchi; G., Viviani; M., DE TAVONATTI; A., Rotondi; L., Bettini; P., Tebaldi; Lanzini, Alberto
Incidence of autoantibodies in selected patients with chronic hepatitis C (CHC) during interferon (IFN) treatment, and prevalence in unselected patients.	1-gen-1995	Sorbara, R.; Pigozzi, Mg; Tebaldi, P.; Franceschini, F.; Lanzini, Alberto
Does inhibition of cholesterol synthesis during ursodeoxycholic acid( UDCA) therapy enrich the pool with UDCA more than UDCA treatment alone?	1-gen-1995	Mb, Panarotto; R., Sorbara; F., Lanzarotto; S., Sosta; Lanzini, Alberto
Does combination of ursodeoxycholic acid (UDCA) and HMG-CoA-Reductase inhibitors enrich the pool with UDCA more than UDCA treatment alone?	1-gen-1995	B., Panarotto; R., Sorbara; F., Lanzarotto; S., Sosta; Lanzini, Alberto
Prevalence of autoantibodies in patients with chronic hepatitis C ( CHC), and incidence during interferon (IFN) treatment.	1-gen-1995	Sorbara, R.; Pigozzi, Mg; Tebaldi, P.; Franceschini, F.; Lanzini, Alberto
Efficacy of interferon (IFN) alone vs IFN+ tauro-ursodeoxycholic acid (T-UDCA) for treatment of chronic hepatitis C ( CHA-C): result at 12 months.	1-gen-1996	R., Sorbara; Mg, Pigozzi; A., Reggiani; D., Quattrocchi; Gp, Lorini; C., Lazzari; G., Viviani; M., DE TAVONATTI; A., Rotondi; L., Bettini; Lanzini, Alberto
Chronic tauro-hyodeoxycholic acid administartion has little effect on bile acid composition and on biliary lipid secretion in man.	1-gen-1999	G., Montani; F., Lanzarotto; S., Sosta; Lanzini, Alberto
Interferon (IFN) sparing effect of adjuvant tauro-ursodeoxycholic acid 8T-UDCA) for treatment of chronic hepatitis C. Results on liver histology.	1-gen-1999	Mg, Pigozzi; L., DI STEFANO; F., Lanzarotto; O., Baisini; A., Reggiani; MG DE, Tavonatti; L., Bettini; Gp, Lorini; A., Cominotti; M., Favret; Lanzini, Alberto
Osteopenia in adult patients with coeliac disease: biochemical characteristics and relationship with bone mineral density.	1-gen-1998	F., Lanzarotto; Lanzini, Alberto

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 8.961 a 8.980 di 15.358

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext12816
open957
restricted798
reserved742
partially open42
embargoed2
mixed1

IRIS Institutional Research Information System - OPENBS Open Archive UniBS